Michael J. Lazar, MD is the first physician to offer the recently FDA-cleared Sonablate® prostate tissue ablation procedure for men in San Francisco, CA.

CHARLOTTE, N.C., NOVEMBER 24, 2015 -- SonaCare Medical, LLC announces that a second location in the United States has performed a prostate tissue ablation procedure using the company's Sonablate® High Intensity Focused Ultrasound (HIFU) technology which FDA granted regulatory authorization for on October 9, 2015.

CHARLOTTE, N.C., OCTOBER  13, 2015 -- SonaCare Medical, LLC, a pioneer in minimally invasive high intensity focused ultrasound (HIFU) technologies, announced today that it received de novo clearance from the U.S. Food and Drug Administration (FDA) to market the Sonablate® 450  in the U.S. for the ablation of prostate tissue. Sonablate® is the first High Intensity Therapeutic Ultrasound (HITU) device to receive FDA regulatory authorization for prostate tissue ablation. SonaCare Medical expects to begin U.S. distribution this October.

Klinik für Prostata established as German demonstration center

JULY 9th 2015. CHARLOTTE, NC -- SonaCare Medical, global leader in high-intensity focused ultrasound (HIFU) ablation devices, announced today the purchase of a newest generation Sonasource with Sonablate® prostate ablation probes by Klinik für Prostata Therapie (Clinic for Prostate Therapy) in Heidelberg, Germany. SonaCare's Germany-based distribution partner Dr. Sennewald Medizintechnik GmbH facilitated the purchase and will collaborate with the clinic and SonaCare to form a German HIFU and Focal Therapy demonstration center in Heidelberg.

Image fusion and targeted ablation programs garner high interest inside and out of the science & industry hall

CHARLOTTE June 4th, 2015 -- The recent 110th Annual Meeting of the American Urological Association in New Orleans, LA, featured a wealth of events and exhibits focusing on less invasive, more targeted treatment of urological cancers. SonaCare Medical, a world-wide leader in the design and manufacture of high intensity focused ultrasound (HIFU) devices, delivered a meeting program that highlighted innovations in image-guided focal ablation including a multi-modal HIFU console Sonasource and associated probes Sonablate® and Sonatherm®.

New fusion collaboration adds additional compatibility for magnetic resonance / Sonablate ultrasound fusion for prostate HIFU planning

CHARLOTTE, N.C., May 19, 2015 -- SonaCare Medical (SCM) , a world leader in minimally - invasive high intensity focused ultrasound (HIFU) technologies , announced plans to work towards a collaboration with Invivo Corporation, a worldwide leader in the development and manufacture of magnetic resonance imaging (MRI) clinical solutions,

Page 4 of 9

HIFU company

Contact

10130 Perimeter Pkwy, Suite 250
      Charlotte, NC 28216

(888) 874-4384

info@SonaCareMedical.com

Mon - Fri: 9:00 - 5:00

Latest News

26 September 2017

Medicare recognizes HIFU prostate ablation as a device-intensive procedure driving new ASC payment going into effect on or after October 1, 2017 CHARLOTTE, N.C., Sept. 20, 2017 /PRNewswire/ -- SonaCare...

29 August 2017

CHARLOTTE, N.C., August 30, 2017 – SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces today the successful collaboration with BK Ultrasound, achieving compatibility...